Mar 31, 2011 | Laboratory News, Laboratory Pathology
Conference on May 5 about clinical laboratory and pathology mergers and acquisitions
For owners and sellers of clinical laboratories and anatomic pathology groups in the United States, the past six months have been rosy times. That’s because buyers have stepped up and paid strong prices for the medical laboratory companies and pathology testing firms that came to market during this time.
Experts predict that merger and acquisition (M&A) activity in the clinical laboratory industry will continue to be robust. Several factors reinforce this optimistic prediction.
(more…)
Dec 29, 2010 | Laboratory News, Laboratory Pathology
Clinical Laboratory and Pathology Customers Will See Few Changes Under New Ownership
Sunquest Information Systems, Inc., has a new owner. Earlier this month, an investment consortium led by Huntsman Gay Capital paid an estimated $208 million to acquire a 51% controlling interest in Sunquest, which is based in Tucson, Arizona. Sunquest’s previous owner, Vista Equity Partners, will retain the remaining 49% of Sunquest’s stock and continue as a minority owner.
Sunquest’s flagship product is a laboratory information system (LIS) that is used by many clinical laboratory companies and hospital/health system laboratories in the United States and a number of other countries. It also sells an anatomic pathology information system, as well as other health informatics software products. The company says it has 1,400 hospital and medical laboratory customers worldwide. (more…)
Nov 19, 2010 | Laboratory Hiring & Human Resources, Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Culture and Benefits Play Significant Role in Employee Satisfaction
Anatomic pathology testing company
Clarient, Inc., was selected as the number three best place to work in healthcare. Based in Aliso Viejo, California, Clarient employs 391 people. In the past year, its voluntary turnover rate was 9%.
(more…)
Oct 22, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
GE’s Acquisition Considered A Sign Of More Deals To Come In The Clinical Laboratory Industry
Here’s more confirmation that anatomic pathology continues to be a big target on the radar screen of big healthcare corporations and Wall Street investors. Today, GE Healthcare, a unit of General Electric Company (NYSE: GE), disclosed it will pay $587 million to acquire Clarient, Inc. (NASDAQ: CLRT), the medical testing laboratory.
For pathologists and clinical laboratory managers, this is further confirmation that GE—one of the world’s major players in molecular imagin and radiology—intends to combine molecular diagnostic technologies used in anatomic pathology with its molecular imaging technologies used in radiology. In the press release about the acquisition, GE wrote that the addition of Clairent would help it create “new integrated tools for the diagnosis and characterization of cancer.”
(more…)